We used available GC patient data from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA), and investigated the role of CXCR4 in GC in relation to the clinical characteristics, tumor purity, immune infiltration, TMB, CYT, survival, and other parameters. This evidence concerns the gene CXCR4 and neoplasm.